MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mundell, S. J.
Right arrow Articles by Kelly, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mundell, S. J.
Right arrow Articles by Kelly, E.

0026-895X/97/060991-08$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 51:991-998 (1997).

A Dominant Negative Mutant of the G Protein-Coupled Receptor Kinase 2 Selectively Attenuates Adenosine A2 Receptor Desensitization

Stuart J. Mundell, Jeffrey L. Benovic, and Eamonn Kelly

Department of Pharmacology, School of Medical Sciences, University of Bristol, Bristol BS8 1TD, UK (S.J.M., E.K.), and Department of Biochemistry and Molecular Pharmacology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 (J.L.B.).

G protein-coupled receptor kinases (GRKs) are thought to be important in mediating the agonist-induced phosphorylation and consequent desensitization of G protein-coupled receptor responses. NG108-15 mouse neuroblastoma X rat glioma cells express a wide range of G protein-coupled receptors and significant levels of GRK2. Therefore, to determine the role of GRK2 in agonist-induced desensitization of various Gs-coupled receptors in NG108-15 cells, we stably transfected cells with a dominant negative mutant GRK2 construct (Lys220Arg). In homogenates prepared from cells overexpressing the dominant negative mutant GRK2, the acute stimulation of adenylyl cyclase by various receptor and nonreceptor agonists was the same as in control cells stably transfected with plasmid only. NG108-15 cells express both A2a and A2b adenosine receptors, which mediate activation of adenylyl cyclase, with both of these responses being subject to agonist-induced desensitization with a t1/2 of 15-20 min. In dominant negative mutant GRK2 cells, the rates of desensitization of A2a and A2b receptor-stimulated adenylyl cyclase were markedly slower than in plasmid transfected controls, with the latter being similar to wild-type cells. After a 20-min treatment with an adenosine agonist, the desensitization of A2a and A2b receptor-stimulated adenylyl cyclase in dominant negative mutant GRK2 cells was less than half that seen in plasmid transfected control cells. On the other hand, the agonist-induced desensitization of secretin and IP-prostanoid receptor-stimulated adenylyl cyclase was the same in dominant negative mutant GRK2 cells as in plasmid transfected control cells. These results indicate that in intact cells, GRK2 may mediate the desensitization of adenosine A2 receptors. Furthermore, there seems to be selectivity of GRK2 action between Gs-coupled receptors because the agonist-induced desensitization of secretin and IP-prostanoid receptor-stimulated adenylyl cyclase was not affected by dominant negative mutant GRK2 overexpression.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
BloodHome page
M. E. Daly, B. B. Dawood, W. A. Lester, I. R. Peake, F. Rodeghiero, A. C. Goodeve, M. Makris, J. T. Wilde, A. D. Mumford, S. P. Watson, et al.
Identification and characterization of a novel P2Y12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM-1VWD study
Blood, April 23, 2009; 113(17): 4110 - 4113.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. J. Mundell, M. L. Jones, A. R. Hardy, J. F. Barton, S. M. Beaucourt, P. B. Conley, and A. W. Poole
Distinct Roles for Protein Kinase C Isoforms in Regulating Platelet Purinergic Receptor Function
Mol. Pharmacol., September 1, 2006; 70(3): 1132 - 1142.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. D. Khoa, M. Postow, J. Danielsson, and B. N. Cronstein
Tumor Necrosis Factor-{alpha} Prevents Desensitization of G{alpha}s-Coupled Receptors by Regulating GRK2 Association with the Plasma Membrane
Mol. Pharmacol., April 1, 2006; 69(4): 1311 - 1319.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. P. Smith, V. J. Ayad, S. J. Mundell, C. A. McArdle, E. Kelly, and A. Lopez Bernal
Internalization and Desensitization of the Oxytocin Receptor Is Inhibited by Dynamin and Clathrin Mutants in Human Embryonic Kidney 293 Cells
Mol. Endocrinol., February 1, 2006; 20(2): 379 - 388.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. J. Horner, S. Osawa, M. D. Schaller, and E. R. Weiss
Phosphorylation of GRK1 and GRK7 by cAMP-dependent Protein Kinase Attenuates Their Enzymatic Activities
J. Biol. Chem., August 5, 2005; 280(31): 28241 - 28250.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. R. Hardy, P. B. Conley, J. Luo, J. L. Benovic, A. W. Poole, and S. J. Mundell
P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms
Blood, May 1, 2005; 105(9): 3552 - 3560.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. R. Hardy, M. L. Jones, S. J. Mundell, and A. W. Poole
Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets
Blood, September 15, 2004; 104(6): 1745 - 1752.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. M. Willets, R. Mistry, S. R. Nahorski, and R. A. J. Challiss
Specificity of G Protein-Coupled Receptor Kinase 6-Mediated Phosphorylation and Regulation of Single-Cell M3 Muscarinic Acetylcholine Receptor Signaling
Mol. Pharmacol., November 1, 2003; 64(5): 1059 - 1068.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Mubagwa and W. Flameng
Adenosine, adenosine receptors and myocardial protection: An updated overview
Cardiovasc Res, October 1, 2001; 52(1): 25 - 39.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. M. Dautzenberg, S. Braun, and R. L. Hauger
GRK3 mediates desensitization of CRF1 receptors: a potential mechanism regulating stress adaptation
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R935 - R946.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. V. Sitaraman, M. Si-Tahar, D. Merlin, G. R. Strohmeier, and J. L. Madara
Polarity of A2b adenosine receptor expression determines characteristics of receptor desensitization
Am J Physiol Cell Physiol, June 1, 2000; 278(6): C1230 - C1236.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Mundell and J. L. Benovic
Selective Regulation of Endogenous G Protein-coupled Receptors by Arrestins in HEK293 Cells
J. Biol. Chem., April 21, 2000; 275(17): 12900 - 12908.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Bunemann and M M. Hosey
G-protein coupled receptor kinases as modulators of G-protein signalling
J. Physiol., May 15, 1999; 517(1): 5 - 23.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Beaumont, M. B. Hepworth, J. S. Luty, E. Kelly, and G. Henderson
Somatostatin Receptor Desensitization in NG108-15 Cells. A CONSEQUENCE OF RECEPTOR SEQUESTRATION
J. Biol. Chem., December 11, 1998; 273(50): 33174 - 33183.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. Ralevic and G. Burnstock
Receptors for Purines and Pyrimidines
Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Innamorati, H. Sadeghi, and M. Birnbaumer
Transient Phosphorylation of the V1a Vasopressin Receptor
J. Biol. Chem., March 20, 1998; 273(12): 7155 - 7161.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
I. Feoktistov and I. Biaggioni
Adenosine A2B Receptors
Pharmacol. Rev., December 1, 1997; 49(4): 381 - 402.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Horie and P. A. Insel
Retrovirally Mediated Transfer of a G Protein-coupled Receptor Kinase (GRK) Dominant-negative Mutant Enhances Endogenous Calcitonin Receptor Signaling in Chinese Hamster Ovary Cells. GRK INHIBITION ENHANCES EXPRESSION OF RECEPTORS AND RECEPTOR mRNA
J. Biol. Chem., September 15, 2000; 275(38): 29433 - 29440.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A.-L. Matharu, S. J. Mundell, J. L. Benovic, and E. Kelly
Rapid Agonist-induced Desensitization and Internalization of the A2B Adenosine Receptor Is Mediated by a Serine Residue Close to the COOH Terminus
J. Biol. Chem., August 3, 2001; 276(32): 30199 - 30207.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. E. McIntire, G. MacCleery, and J. C. Garrison
The G Protein beta Subunit Is a Determinant in the Coupling of Gs to the beta 1-Adrenergic and A2a Adenosine Receptors
J. Biol. Chem., May 4, 2001; 276(19): 15801 - 15809.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics